CONDUIT PHARMACEUTICALS INC (CDT) Stock Income Statement
NASDAQ:CDT - Nasdaq - US20678X1063 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 12.80M | 5.26M | 1.20M | 0.00 | |||
| Research and Development | 3.34M | 90.00K | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 9.46M | 5.17M | 1.20M | N/A | |||
| Operating Income | -12.80M | -5.26M | -1.20M | 0.00 | |||
| Interest Income/Expense | -640.00K | -196.00K | 1.98M | N/A | |||
| Other Income/Expense | -176.00K | 4.92M | N/A | N/A | |||
| Income Before Taxes | -13.62M | -535.00K | 770.00K | 0.00 | |||
| Income Tax | N/A | N/A | 370.00K | N/A | |||
| Net Income | -13.62M | -535.00K | 400.00K | 0.00 | |||
| Per Share Data | |||||||
| EPS Diluted Total Ops | -0.17 | -0.01 | 0.03 | 0.00 | |||
| Statistics | |||||||
All data in USD